Colloidal Silver Stabilized Botulinum Toxin for Extended Muscle Relaxation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Botulinum toxin treatments for medical and cosmetic purposes require repeated administration due to degradation by the body, leading to temporary relief rather than a cure for conditions such as muscle spasms and wrinkles.

Innovation Solution

Combining botulinum toxin with colloidal silver particles to create compositions and kits for medical and cosmetic use, where the colloidal silver enhances the stability and efficacy of botulinum toxin, prolonging its effects and increasing its shelf life.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If botulinum toxin is administered alone, then it provides therapeutic and cosmetic effects, but the effects are temporary and require repeated administration due to body degradation

Engineering Contradiction:

Improveduration of muscle relaxation effectVSAvoidstability of botulinum toxin

Core Design Contradiction:

Duration of action of moving objectVSReliability

Solution Approach 1:

The patent combines botulinum toxin with colloidal silver particles to create a composite formulation. The colloidal silver particles serve as a stabilizing carrier that protects the botulinum toxin from degradation by bodily enzymes and immune systems, thereby extending the duration of muscle relaxation effects from 10-12 weeks to potentially longer periods while maintaining therapeutic reliability

Inventive Principle:

Principle #40Composite materials

2Reliability

If botulinum toxin is administered repeatedly, then therapeutic effects are maintained, but treatment frequency increases and patient burden increases

Engineering Contradiction:

Improvemaintenance of therapeutic effectVSAvoidtime lost to repeated injections

Core Design Contradiction:

ReliabilityVSLoss of time

Solution Approach 1:

The colloidal silver particles are prepared in advance as a stabilizing matrix that pre-protects the botulinum toxin before administration. This preliminary stabilization action ensures that once injected, the toxin remains active longer in the body, thereby reducing the frequency of required injections and the time patients must spend on repeated treatments

Inventive Principle:

Principle #10Preliminary action

3Duration of action of stationary object

If botulinum toxin is stored for extended periods, then shelf life is extended, but stability and efficacy may degrade

Engineering Contradiction:

Improveshelf life of reconstituted productVSAvoidstability of botulinum toxin

Core Design Contradiction:

Duration of action of stationary objectVSStability of the object's composition

Solution Approach 1:

The colloidal silver particles act as an intermediary protective matrix between the botulinum toxin and degrading environmental factors during storage. This intermediary structure maintains the toxin's stability and biological activity throughout extended storage periods, allowing the reconstituted product to remain effective for longer shelf lives without compromising composition integrity

Inventive Principle:

Principle #24Intermediary (Mediator)

Data Source

PatentUS11304973B2Botulinum toxin and colloidal silver particles

Publication Date: 2022.04.19 DR ANDREW WILLOUGHBY INC

AI summary

Botulinum toxin is combined with colloidal silver particles to provide improved compositions for use in medical and cosmetic treatments.